There is debate surrounding the use of PCSK9 inhibitors among patients who are intolerant to statins. What is your opinion? Let us know by taking our poll.
Statins can help manage severe dyslipidemia in young patients. Do you think it is prescribed enough among this patient population? Share your thoughts by answering this poll.
